When clinical trials fail to address treatment gaps: the failure of niacin-laropiprant to reduce cardiovascular events. uri icon

Overview

publication date

  • June 1, 2013

Research

keywords

  • Arterial Occlusive Diseases
  • Chemical and Drug Induced Liver Injury
  • Hypolipidemic Agents
  • Indoles
  • Muscular Diseases
  • Niacin

Identity

Scopus Document Identifier

  • 84876184735

Digital Object Identifier (DOI)

  • 10.1007/s11883-013-0332-x

PubMed ID

  • 23605289

Additional Document Info

volume

  • 15

issue

  • 6